Search
ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
April 16, 2026 - … information, call 1-800-545-5979 or go to foundayo.lilly.com . This summary provides basic information about Foundayo … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram and LinkedIn … information, call 1-800-545-5979 or go to foundayo.lilly.com . This summary provides basic information about Foundayo …
La FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o agua
April 2, 2026 - … información acerca de Foundayo, visite www.foundayo.lilly.com . Acerca de Foundayo (orforglipron) 4 Foundayo™ … vía oral. Llama al 1-800-545-5979 o visita foundayo.lilly.com para más información. Este resumen proporciona … términos y condiciones. Más información en foundayo.lilly.com/es. Foundayo. Información de Prescripción. Lilly USA, …
Foundayo™ (orforglipron), la nueva pastilla GLP-1 de Lilly que se administra por vía oral para la pérdida de peso, ahora está disponible en Estados Unidos.
April 9, 2026 - … Para entender sus opciones, visite www.foundayo.lilly.com/es . Respaldado por el riguroso programa de estudios … información acerca de Foundayo, visite www.foundayo.lilly.com/es . Para más información acerca de LillyDirect, visite www.lilly.com/lillydirect Acceso a medicinas para la obesidad La …
Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
April 9, 2026 - … . To understand your options, visit www.foundayo.lilly.com . Supported by the rigorous ATTAIN clinical trial … learn more about Foundayo, please visit www.foundayo.lilly.com . To learn more about LillyDirect, please visit www.lilly.com/lillydirect . Obesity Medicine Access Obesity remains one …
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
April 1, 2026 - … about Foundayo, please visit www.foundayo.lilly.com . About Foundayo (orforglipron) 4 Foundayo™ … information, call 1-800-545-5979 or go to foundayo.lilly.com . This summary provides basic information about Foundayo … 4 Terms and conditions apply. Learn more at foundayo.lilly.com . Foundayo. Prescribing Information. Lilly USA, LLC . Ma …
Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
February 26, 2026 - … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram and LinkedIn … any other companies. Refer to: Niki Biro ; niki_biro@lilly.com ; 317-358-9074 (Media) Michael Czapar ; … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , …
Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)
February 19, 2026 - … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram , and … USA, LLC . Refer to: Kelly Hoffman ; kelly.hoffman@lilly.com ; 765-736-2555 (Lilly media) Michael Czapar; … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , …
Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
January 20, 2026 - … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram , and … release. Refer to: Michelle Webb; michelle.webb@lilly.com ; 463-206-4463 (Media) Michael Czapar ; … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , …
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
December 18, 2025 - … 1-800-LillyRx (1-800-545-5979) or go to www.zepbound.lilly.com . This summary provides basic information about Zepbound … 1-800-LillyRX (800-545-5979) or go to www.mounjaro.lilly.com . This summary provides basic information about Mounjaro … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram …
Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
November 24, 2025 - … full Prescribing Information , available at www.Verzenio.com . INDICATIONS FOR VERZENIO VERZENIO is a kinase inhibitor … are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news , or follow us on Facebook , Instagram , and … full Prescribing Information , available at www.Verzenio.com . INDICATIONS FOR VERZENIO VERZENIO is a kinase inhibitor …